|
|
|
| home > white papers > Contemporary Issues in Comparator Trial Supply - Clinigen CTS |
|
|
 WHITE PAPERS |
|
Clinigen CTS
|
|
Contemporary Issues in Comparator Trial Supply
|
|
The past five years has seen a great deal of change in clinical trial management. As the bio-pharma industry looks to speed development times and consolidate new product pipelines, in a quest for improved R&D efficiency, it is no surprise that phase III trial design, planning and execution in particular has been under great scrutiny. Cost of comparator agents alone has escalated to up to $100m per year for top companies (and is predicted to grow further). Consequently innovative approaches, novel project planning and increasingly close partnerships with specialist outsourcing service providers have come to the fore.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
ADM Supports Clinical Trial into Effects of Probiotic Supplements for COVID-19 Patients in Hospital Care
ADM and Hospital de Sagunto, one of the largest medical
centers in the Valencia region, today announce their partnership for a
clinical trial into the effects of using a food supplement containing
live microbial strains to promote gut microbiome balance and help
improve health functions related to outcomes for COVID-19 patients in
high-risk groups.
On 18th March Dr Xavier Cortés, gastroenterologist at Hospital de
Sagunto, communicated with medical staff in China who had observed that
many COVID-19 patients had exhibited abnormal changes in their gut
microbiome.
More info >> |
|
 |
White Papers |
 |
|
 |
Industry Events |
 |
Clinical Operations in Oncology Trials West Coast
17-18 November 2020, Hilton San Francisco Airport Bayfront
Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >> |
|
|
|
